Particularly, the protective effect of ERβ in gliomas is also supported by the fact that the incidence rate of this cancer is smaller in women than in men [44], and more importantly, the use of exogenous estrogens further reduces this incidence [45]. The gene discussed is ESR2; the disease is cancer.